-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (GOTU, GSX)

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Gaotu Techedu Inc. (NYSE: GOTU, GSX) American depository shares ("ADSs") between March 5, 2021 and July 23, 2021, for violations of the Securities Exchange Act of 1934. Gaotu purports to be a technology-driven education company, providing online K-12 after-school tutoring services in the People's Republic of China.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Gaotu. Shareholders who want to act as lead plaintiff for the class must file their papers by February 28, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: Gaotu Techedu Inc. (GOTU) Failed to Disclose the Impact of China's Ban on For-Profit Tutoring on Its Business Prospects

According to the complaint, during the class period, defendants failed to disclose among other things that: (1) China was barring tutoring for profit in core school subjects and the policy change would restrict foreign investment in a sector that had become essential to success in Chinese school exams; and (2) the impact such regulations would have on Gaotu’s operations and profitability and the value of Company securities.

On July 23, 2021, Reuters reported that China is barring tutoring for profit in core school subjects, which triggered a heavy sell-off in shares of tutoring firms. Further, "[a]ll institutions offering tutoring on the school curriculum will be registered as non-profit organisations, and no new licences [sic] will be granted." On this news, the price of Gaotu's ADSs fell 63.3% to close at $3.52 per ADS on July 23, 2021, damaging investors.

Then, on November 6, 2021, the Financial Times published an article entitled "How China's tech bosses cashed out at the right time-Sales of US-listed shares came ahead of significant moves in price." The article detailed the unreported trade of a shell company holding shares of executives at Gaotu. The sale occurred in March 2021, ahead of the ban on for-profit tutoring, when the shares were worth as much as $119m, compared to their $4m value at the time of reporting.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Gaotu Techedu Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GOTU

Release Summary
Gaotu Techedu Inc. (GOTU) Failed to Disclose the Impact of China's Ban on For-Profit Tutoring on Its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom